HHS in 2018 rescinded a request for DEA to classify kratom as a Schedule I controlled substance, citing the potential for adverse health consequences.

The Thailand House of Representatives voted to remove Kratom from the Thailand’s narcotics list and classify it as a controlled substance

Kratom health benefits include helping women with symptoms of PMS such as mood swings, sleep changes, cramping, & period pain. Natural relief is possible.

Chronic administration of opioids produces physical dependence and opioid-induced hyperalgesia. Users claim the Thai traditional tea “kratom” and component alkaloid mitragynine ameliorate opioid withdrawal without increased sensitivity to pain. Testing these claims, we assessed the combined kratom a …

Speciociliatine is a minor indole alkaloid found in kratom, a southeast Asian medicinal plant, used for centuries to increase energy, enhance mood, and mitigate pain and opioid dependence. An ultra-performance liquid chromatography tandem mass spectrometry method was developed and validated to quant …

Mitragynine is the main alkaloid isolated from the leaves of Mitragyna speciosa Korth (Kratom). Kratom has been widely used to relieve pain and opioid withdrawal symptoms in humans but may also cause memory deficits. Here we investigated the changes in brain electroencephalogram (EEG) activity after …

Learn how to improve your health and wellness with the healing powers of kratom, the CBD of opioids. In this groundbreaking book she explains the current state of research on how kratom works in the body to provide natural balance to the opioid system without the dangers of synthetic prescription opioids.

Thursday, February 11 at 3:00pm PST with Dr. Michele Ross. Curious about kratom? Dr. Ross answers your questions about the safety & benefits of kratom tea for chronic pain. Dr. Ross is the founder of AURA Therapeutics, the first kratom brand for women.

AURA Therapeutics is on a mission to break the stigma around kratom and make it safer and more accessible to women. Studies will be lead by Dr. Michele Ross.